Ulcerative colitis trials in Germany

In Germany 38 Also abroad 381

38 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
Wild Blueberries in Colitis
Where
Bamberg
Age
18 years and over
People
60
Run by
Universität Duisburg-Essen
See details and how to joinNCT06698601
Phase 2/3Taking people
A phase 2/3, multicenter, randomized, double-blind study to evaluate the efficacy, safety, pharmacokinetics and pharmacodynamics of oral ozanimod (RPC1063) in pediatric subjects with moderately to severely active ulcerative colitis with an inadequate response to conventional therapy.
Where
Dresden, Leipzig, Munich
Age
Up to 17 years
People
62 worldwide
Run by
Bristol-Myers Squibb Services Unlimited Company
See details and how to join2023-509248-86-00 · EU 2023-509248-86-00
Phase 2Taking people
A Phase 2 Platform Study to Evaluate Therapies for Inflammatory Bowel Disease
Where
Berlin, Remscheid, Tuebingen, Ulm
Age
18 years and over
People
54 worldwide
Run by
Mirador Therapeutics Inc.
See details and how to join2025-522001-38-00 · EU 2025-522001-38-00
Phase 1Taking people
A randomized, double-blind, placebo-controlled, single and multiple-dose-escalation, phase 1 study in healthy volunteers and patients with ulcerative colitis to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of GRT-001 (MONOlith trial)
Where
Berlin
Age
18 years and over
People
112
Run by
Granite Bio AG
See details and how to join2023-507547-11-00 · EU 2023-507547-11-00
Phase 2Taking people
A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
Where
Frankfurt am Main, Frankfurt Am Main, Kiel, Ludwigshafen am Rhein, Mannheim, Tuebingen, Ulm
Age
18 years to 75 years
People
192 worldwide
Run by
Takeda
See details and how to joinNCT06764615 · EU 2024-518914-18-00
No phaseTaking people
CEDUR - German IBD Registry
Where
Hamburg
Age
18 years and over
People
10,000
Run by
ImmunoRegister gUG
See details and how to joinNCT07319442
Phase 4Taking people
Efficacy of Top-down Therapy With Mirikizumab Versus Standard of Care With Azathioprine in Patients With Newly Diagnosed Moderate-to-severe Ulcerative Colitis
Where
Augsburg, Berlin, Dornstadt, Friedrichsthal, Halle (Saale), Hamburg, Hamm, Hannover, Iserlohn, Jerichow, Kassel, Kiel, Leipzig, Lueneburg, Magdeburg, Marburg, Pforzheim, Potsdam, Velbert
Age
18 years to 75 years
People
300
Run by
University Hospital Schleswig-Holstein
See details and how to joinNCT07235904 · EU 2025-522585-72-00
Phase 2Not yet taking people in Germany
Multi-center, single-arm, phase II clinical trial evaluating efficacy and in-vivo homing of adoptively transferred autologous ex-vivo expanded regulatory T cells in adults with ulcerative colitis
Where
Berlin, Erlangen
Age
18 years and over
People
30
Run by
Universitaetsklinikum Erlangen AöR
See details and how to join2025-520628-11-00 · EU 2025-520628-11-00
No phaseTaking people
Molecular Inflammation Board at the Center for Personalized Medicine
Where
Tübingen
Age
18 years and over
People
3,000
Run by
University Hospital Tuebingen
See details and how to joinNCT07132333
No phaseTaking people
Texture and Color Enhancement Imaging (TXI) for Inflammation Assessment in Patients With Inflammatory Bowel Diseases
Where
Ulm
Age
18 years and over
People
80
Run by
University of Ulm
See details and how to joinNCT06892990
No phaseTaking people
AI-driven Narrow-band Imaging Score for Disease Assessment and Outcome Prediction in Ulcerative Colitis
Where
Lüneburg
Age
18 years to 75 years
People
300 worldwide
Run by
University College Cork
See details and how to joinNCT06709209
No phaseTaking people
CEDATA GPGE - a Patient Registry for Children and Adolescents With Inflammatory Bowel Disease
Where
Giessen
Age
Up to 18 years
People
6,300
Run by
University of Giessen
See details and how to joinNCT06606756
No phaseTaking people
German Spondyloarthritis Inception Cohort
Where
Berlin
People
1,000
Run by
Charite University, Berlin, Germany
See details and how to joinNCT01277419